Companies Dominating the Crohn's Disease Treatment Landscape
- Johnson & Johnson Services Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Pfizer Inc.
- Allergan
- AbbVie Inc.
- Bayer AG
- Amgen Inc.
- Takeda Pharmaceutical Company Limited
- UCB S.A.
- Ferring B.V.
- Eli Lilly Company
- Hoffman-La Roche
- Bristol-Myers Squib
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2025, the industry size of crohn's disease treatment is estimated at USD 14.55 billion.
Crohn's Disease Treatment Market size was over USD 14.05 billion in 2024 and is anticipated to cross USD 23.99 billion by 2037, growing at more than 4.2% CAGR during the forecast period i.e., between 2025-2037.
Asia Pacific industry is anticipated to account for largest revenue share by 2037, owing to increasing awareness about Crohn’s disease, and need to develop innovative inflammatory bowel disease treatment solutions in the region.
The major players in the market are Pfizer Inc., Allergan, AbbVie Inc., Bayer AG, Amgen Inc., Takeda Pharmaceutical Company Limited, UCB S.A., Ferring B.V., Eli Lilly Company, Hoffman-La Roche, Bristol-Myers Squibb, among others.
